Embedded for life!
Permanent Tissue-Integrating Implants
Our Biomimetic Technology
Biomimetics is the emulation of the models, systems, and elements of nature for the purpose of solving complex human problems*
At CorNeat Vision we aim to significantly impact the well-being of millions by addressing unmet medical needs across several therapeutic fields. Our disruptive platform material technology, the CorNeat EverMatrix™, harnesses the unique characteristics of microstructures of the human body to develop completely synthetic biomimetic implants which mend, reinforce, replace, and bio-integrate with resident tissue.
The EverMatrix™, which was optimized in-vitro and validated in-vivo, enables permanent implants to bio-mechanically integrate with live tissue without triggering an adverse immune system (foreign body) response that leads to encapsulation.
It is 100% synthetic nondegradable porous material that mimics the micro-structure of the Extracellular Matrix (ECM), the natural biological collagen mesh that provides structural and biochemical support to surrounding cells. When implanted, the EverMatrix™ stimulates cellular proliferation leading to progressive tissue integration.
*Vincent, Julian F. V.; et al. (22 August 2006). "Biomimetics: its practice and theory". Journal of the Royal Society Interface. 3 (9): 471–482. doi:10.1098/rsif.2006.0127. PMC 1664643. PMID 16849244.
Biomechanical integration of implants to tissue
Permanently attach and integrate synthetic material with live human tissue without rejection
Concealment of implants and sensors
Conceal implants and “hide” them from the immune system
Fabrication of membranes and tissue barriers
Permanent barriers for controlling tissue regeneration
Soft tissue repair and permanent reinforcment
Provide permanent and firm structural support to soft tissue
Our Biomimetic Implants Are:
Our Mission: Harness Biomimicry For Improving Health
Our mission is to promote health and equality worldwide through innovative biomimetic medical solutions that are widely accessible.
Our goal at CorNeat Vision is to innovate, collaborate and grow in our efforts to introduce biomimetic implants with the aim of permanently resolving medical and surgical challenges in diversified therapeutic fields.
We promote permanent solutions to medical problems through an active learning process, placing the physician's ease-of-use as a top priority.
About CorNeat Vision
CorNeat Vision was established in December 2015 with the goal of developing, producing and introducing to global markets a scalable artificial solution for global corneal blindness, while eliminating the dependency on donor tissue.
Impressed with our pre-clinical trials, which demonstrated progressive and seamless tissue integration of our biomimetic material, the EverMatrix™, the company's scientific advisory board suggested replacing the use of tectonic tissue grafts with the EverMatrix™ in other ophthalmic surgical procedures. Realizing the potential, we registered IP for additional devices in the ophthalmic space.
In order to fully exploit the business potential of the EverMatrix™ and to maximize its impact on human health, we have expanded our IP and product portfolio and introduced solutions in additional fields of medicine. Our first such product is aimed at permanently resolving gingival recession and replacing the current use of degradable tissue grafts.
Our two initial products, the CorNeat EverPatch (synthetic tissue substitute) and the CorNeat KPro (synthetic cornea), are in clinical trials and expected to receive initial marketing approval in 2023 and 2024, respectively.